Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ricardo Enríquez, Juan Carlos Rodríguez, Ana Esther Sirvent, Francisco Amorós, Francisco Ardoy, Manuel Álvarez & Gloria Royo. (2007) Prevalence of hepatitis B and C markers in glomerular diseases. Scandinavian Journal of Urology and Nephrology 41:6, pages 535-538.
Read now
Read now
Articles from other publishers (36)
Alicia Estirado Gómez, Soledad Justo Gil, Aurora Limia, Ana Avellón, Araceli Arce Arnáez, Raquel González-Rubio, Asunción Diaz & Julia del Amo. (2021) Prevalence and undiagnosed fraction of hepatitis C infection in 2018 in Spain: results from a national population-based survey. European Journal of Public Health 31:6, pages 1117-1122.
Crossref
Crossref
Jose Luis Calleja Panero, Sabela Lens García, Miguel Fernández Bermejo & Javier Crespo García. (2019) Definition of the profiles of hepatitis C virus patients based on the identification of risky practices in Spain. Revista Española de Enfermedades Digestivas 111.
Crossref
Crossref
Laura Gómez-Escolar Viejo, Antonio García Herola, Isabel Sáez Lloret, Fernando Sánchez Ruano, Inmaculada Clemente Paulino, Cristina Quílez Ivorra, Isabel Almenta Saavedra, David Martínez Pérez & Jaime Valverde de la Osa. (2018) Screening of hepatitis C virus infection in adult general population in Spain. European Journal of Gastroenterology & Hepatology 30:9, pages 1077-1081.
Crossref
Crossref
Ivan Dlouhy, Miguel Á. Torrente, Sabela Lens, Jordina Rovira, Laura Magnano, Eva Giné, Julio Delgado, Olga Balagué, Antonio Martínez, Elías Campo, Xavier Forns, José M. Sánchez-Tapias & Armando López-Guillermo. (2016) Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Annals of Hematology 96:3, pages 405-410.
Crossref
Crossref
Francisco Javier García-Alonso, Daniel Bonillo-Cambrodón, Andrea Bermejo, Jesús García-Martínez, María Hernández-Tejero, Paz Valer López Fando, Belén Piqueras & Fernando Bermejo. (2016) Acceptance, yield and feasibility of attaching HCV birth cohort screening to colorectal cancer screening in Spain. Digestive and Liver Disease 48:10, pages 1237-1242.
Crossref
Crossref
A. Genowska, J. Jamiołkowski, E. Rodakowska, J. Fryc, M. Kozela & A. Pająk. (2015) Changing 14-year trends in the epidemiology of hepatitis B virus infection in rural and urban Central-Eastern European areas. Journal of Viral Hepatitis 22:12, pages 1061-1067.
Crossref
Crossref
Mohamed A Daw & Abdallah El-Bouzedi. (2014) Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infectious Diseases 14:1.
Crossref
Crossref
Conrado M. Fernández Rodriguez & Maria Luisa Gutierrez Garcia. (2014) Impacto del tratamiento antiviral en la historia natural del virus de la hepatitis C. Gastroenterología y Hepatología 37:10, pages 583-592.
Crossref
Crossref
Sylvie Deuffic–Burban, Pierre Deltenre, Maria Buti, Tommaso Stroffolini, Julie Parkes, Nikolai Mühlberger, Uwe Siebert, Christophe Moreno, Angelos Hatzakis, William Rosenberg, Stefan Zeuzem & Philippe Mathurin. (2012) Predicted Effects of Treatment for HCV Infection Vary Among European Countries. Gastroenterology 143:4, pages 974-985.e14.
Crossref
Crossref
Francisco Javier García-Alonso, Rosa María Martín-Mateos & Víctor Moreira Vicente. (2012) Tratamiento farmacológico de la hepatitis B aguda. Medicina Clínica 138:14, pages 633-637.
Crossref
Crossref
Giuseppe La Torre, Maria Rosaria Gualano, Leda Semyonov, Nicola Nicolotti, Walter Ricciardi & Antonio Boccia. (2011) Hepatitis C Virus infections trends in Italy, 1996-2006. Hepatitis Monthly 11:11, pages 895-900.
Crossref
Crossref
Carme Loras, Cristina Saro, Ferràn Gonzalez-Huix, Miguel Mínguez, Olga Merino, Javier P Gisbert, Jesús Barrio, Antonio Bernal, Ana Gutiérrez, Marta Piqueras, Xavier Calvet, Montserrat Andreu, Agueda Abad, Daniel Ginard, Luis Bujanda, Julián Panés, Miquel Torres, Fernando Fernández-Bañares, Josep M Viver & Maria Esteve. (2008) Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study. The American Journal of Gastroenterology 104:1, pages 57-63.
Crossref
Crossref
Tanja Marschall, Mirjam Kretzschmar, Marie-Josee J. Mangen & Solko Schalm. (2008) High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. European Journal of Gastroenterology & Hepatology 20:12, pages 1214-1225.
Crossref
Crossref
Francesca Cainelli. (2008) Hepatitis C Virus Infection in the Elderly. Drugs & Aging 25:1, pages 9-18.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Juan F. López-Caleya, Vicente Martín, Laura Martín, Rosario Pérez-Simón, José A. Carro & Manuel Alcoba. (2006) Prevalencia de coinfección por virus de la inmunodeficiencia humana y virus de la hepatitis C en el área de salud de León: 1992-2000. Enfermedades Infecciosas y Microbiología Clínica 24:6, pages 365-369.
Crossref
Crossref
Miguel Bruguera & Xavier Forns. (2006) Hepatitis C en España. Medicina Clínica 127:3, pages 113-117.
Crossref
Crossref
Jose M. Nieto & Sammy Saab. (2006) Outcomes of liver transplantation using Hepatitis B core-positive liver grafts: Implications for prophylaxis. Current Hepatitis Reports 5:1, pages 33-39.
Crossref
Crossref
Norah Terrault, Bruno Roche & Didier Samuel. (2005) Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective. Liver Transplantation 11:7, pages 716-732.
Crossref
Crossref
Filippo Ansaldi, Bianca Bruzzone, Stefania Salmaso, Maria Cristina Rota, Paolo Durando, Roberto Gasparini & Giancarlo Icardi. (2005) Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. Journal of Medical Virology 76:3, pages 327-332.
Crossref
Crossref
Juan Fernando Gallegos-Orozco, Hugo E. Vargas & Jorge Rakela. (2004) Virologically compromised donor grafts in liver transplantation. Journal of Hepatology 41:4, pages 512-521.
Crossref
Crossref
M. Campins, M.D. Reina, J. Vaqué, J.M. Elorza, I. Esteban, L. Cabero & J. Xercavins. (2004) Prevalencia de infección por el virus de la hepatitis C en pacientes a las que se practicó cirugía obstétrica y ginecológica en un hospital de tercer nivel. Progresos de Obstetricia y Ginecología 47:2, pages 77-82.
Crossref
Crossref
Jerónimo Jaqueti & Ignacio Vírseda. (2003) Determinaciones serológicas en pacientes psiquiátricos que ingresan en hospitales de agudos. Medicina Clínica 121:5, pages 198-199.
Crossref
Crossref
M.A. Balogun, M.E. Ramsay, L.M. Hesketh, N. Andrews, K.P. Osborne, N.J. Gay & P. Morgan-Capner. (2002) The Prevalence of Hepatitis C in England and Wales. Journal of Infection 45:4, pages 219-226.
Crossref
Crossref
R. Barcena Marugan, F. Garcia-Hoz, M. Vazquez Romero, R. Nash, M. Mateos, R. Gonzalez Alonso, M. Garcia Gonzalez & A. Garcia Plaza. (2002) Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination. The American Journal of Gastroenterology 97:9, pages 2398-2401.
Crossref
Crossref
Sandro Vento & Francesca Cainelli. (2002) Does hepatitis C virus cause severe liver disease only in people who drink alcohol?. The Lancet Infectious Diseases 2:5, pages 303-309.
Crossref
Crossref
Arturo Pereira & Miquel Bruguera. (2002) Predicción del impacto sanitario de la hepatitis C en la población de Cataluña. Medicina Clínica 119:10, pages 377-381.
Crossref
Crossref
Ricard Solá, Eva Cruz de Castro, Manuela Hombrados, Ramón Planas, Susanna Coll, Rosend Jardí, Jordi Sunyer, Maria Isabel Covas & Jaume Marrugat. (2002) Prevalencia de las hepatitis B y C en diversas comarcas de Cataluña: estudio transversal. Medicina Clínica 119:3, pages 90-95.
Crossref
Crossref
M G Brook. (2016) European guideline for the management of hepatitis B and C virus infections. International Journal of STD & AIDS 12:2_suppl, pages 48-57.
Crossref
Crossref
Wolfgang Jilg, Barbara Hottentr�ger, Klaus Weinberger, Klaus Schlottmann, Egbert Frick, Axel Holstege, J�rgen Sch�lmerich & Klaus-Dieter Palitzsch. (2001) Prevalence of markers of hepatitis B in the adult German population. Journal of Medical Virology 63:2, pages 96-102.
Crossref
Crossref
Rafael Bárcena Marugán, S. García Garzón, A. López San Román, E. Peña González, A. García Plaza, R. Nash, R. Férnandez Muñoza & M. Mateosa. (2001) Riesgo de transmisión del virus de la hepatitis B de donantes de hígado anti-HBc positivos. Medicina Clínica 116:4, pages 125-128.
Crossref
Crossref
Stefano Bellentani, Lucia Miglioli, Flora Masutti, Gioconda Saccoccio & Claudio Tiribelli. (2000) Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery. Microbes and Infection 2:14, pages 1757-1763.
Crossref
Crossref
. (1999) Prevalence of Hepatitis C Virus Infection in the United States. New England Journal of Medicine 341:27, pages 2093-2095.
Crossref
Crossref
G. Maggi, S. Armitano, L. Brambilla, M. Brenna, M. Cairo, G. Galvani, D. Gola, K. Komla‐Ebri, E. Marmondi, G. Perricone, M. Posca, P. G. Vegezzi, C. Vergani & Giuseppe De Leo. (2008) Hepatitis C infection in an Italian population not selected for risk factors. Liver 19:5, pages 427-431.
Crossref
Crossref
María J Romero, Francisco Bosch-Morell, Belén Romero, José M Rodrigo, Miguel A Serra & Francisco J Romero. (1998) Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radical Biology and Medicine 25:9, pages 993-997.
Crossref
Crossref
F J Romero, F Bosch-Morell, M J Romero, E J Jareño, B Romero, N Marín & J Romá. (1998) Lipid peroxidation products and antioxidants in human disease.. Environmental Health Perspectives 106:suppl 5, pages 1229-1234.
Crossref
Crossref